COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico-Reference-Cited by-同舟云学术

COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico

Published:2021-10-28 Issue:1 Volume:65 Page:65-70
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Guzmán‐Castro Salvador¹,Chora‐Hernandez Luis David¹,Trujillo‐Alonso Gersain¹,Calvo‐Villalobos Ivan¹,Sanchez‐Rangel Antonio¹,Ferrer‐Alpuin Edgar¹,Ruiz‐Jimenez Miguel²,Corzo‐Leon Dora E.³^ORCID

Affiliation:

1. Hospital General “Dr. Miguel Silva” SSM Morelia Mexico

2. Microbiology Gerency Asesores Diagnóstico Clínico Puebla Mexico

3. The Institute of Medical Sciences University of Aberdeen Aberdeen UK

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13383

Reference20 articles.

1. World Health Organization.WHO Coronavirus (COVID‐19) dashboard. Accessed September 29 2021.https://covid19.who.int/

2. Dexamethasone in Hospitalized Patients with Covid-19

3. COVID-19, corticosteroids and public health: a reappraisal

4. ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme;The Lancet Regional Health - Europe;2024-10

2. Pathogenesis of COVID-19-Associated Mucormycosis: An Updated Evidence-Based Review;Current Fungal Infection Reports;2024-02-01

3. Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review;Frontiers in Immunology;2023-09-25

4. The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study;The Journal of Infection in Developing Countries;2023-06-30

5. Dexamethasone/methylprednisolone/prednisone;Reactions Weekly;2023-01-07